The experimental study of novel lung segmentectomy using vitamin B2 and photodynamic thoracoscopid system.

The experimental study of novel lung segmentectomy using vitamin B2 and photodynamic thoracoscopid system. - The experimental study of novel lung segmentectomy.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021259

Enrollment

Registered

2016-02-29

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer and metastatic lung tumor

Interventions

The lung segmentectomy using vitamin B2 and photodynamic diagnosis during thoracoscopic surgery.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The operative candidates for lung cancer or metastatic lung tumor.

Exclusion criteria

Exclusion criteria: No indication of lung segmentectomy.

Design outcomes

Primary

Measure	Time frame
Safety of Vitamin B2. Efficacy of novel lung segmentectomy. Assessment:After surgery immediately, 2 weeks, and three months.	—

Countries

Japan

Contacts

Public ContactMunehisa Takata

Kanazawa University Department of Thoracic Cardiovascular and General Surgery

takatamunehisa0223@yahoo.co.jp076-265-2354

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026